English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
Tamoxifen vs Aromatase Inhibitors and highlights of San Antonio Breast Cancer Symposium
SABCS 2008
10 - 14 Dec 2008
Please rate this video
The information in this video was of interest to me
The information in this video is likely to improve my clinical practice or research
I would recommend this video to my colleagues
Published:
9 Jan 2009
Views:
17626
Rating:
Save
Rate video
Professor Mitch Dowsett, Professor of Biochemical Endocrinology at the Institute of Cancer Research
Highlights of the San Antonio Breast Cancer Symposium, Aromatase Inhibtors vs Tamoxifen, Survival Benefit, BIG 1-98, Letrozole
Categories:
Breast
Drug development
Hormones/endocrine
Related Videos
SOFT study: Clinical relevance of genomic alterations in premenopausal HR+...
Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia
28 Mar 2023
Spindle cell lesions of the breast
Prof Cecily Quinn - St Vincent’s University Hospital, Dublin, Ireland
1 Feb 2023
Management of HER2 positive metastatic breast cancer treatment algorithm
Prof Sandra Swain - Georgetown University Medical Center, Washington DC, USA
31 Jan 2023
Elacestrant shows improved PFS in ER-positive/HER2-negative mBC
Dr Virginia Kaklamani - UT Health San Antonio MD Anderson Cancer Center, San...
13 Jan 2023
A genomic assay may predict long-term prognosis in premenopausal patients with...
Dr Ruth O'Regan - University of Rochester, Rochester, USA
19 Dec 2022
Abemaciclib plus trastuzumab fulvestrant increased OS for HR+, HER2+ advanced...
Dr Sara Tolaney - Dana-Farber Cancer Institute, Boston, USA
21 Sep 2022
Lasofoxifene shows promise for women with ESR1-mutated mBC
Prof Hope Rugo - UCSF Helen Diller Family Comprehensive Cancer Center, San...
11 Sep 2022
Sacituzumab govitecan increases PFS for HR+/HER2- metastatic breast cancer
Dr Hope Rugo - University of California San Francisco, San Francisco, USA
4 Jun 2022
The RxPONDER trial and its impact on best clinical practice
Prof Christos Markopoulos and Prof Giuseppe Curigliano
17 Dec 2021
More from
e
cancer